Background Induction of labour is a common obstetric procedure. Both mechanical (eg, Foley catheters) and pharmacological methods (eg, prostaglandins) are used for induction of labour in women with an unfavourable cervix. We aimed to compare the eff ectiveness and safety of induction of labour with a Foley catheter with induction with vaginal prostaglandin E2 gel.
Introduction
Induction of labour is a common obstetric interventionworldwide, 20-30% of deliveries are induced. [1] [2] [3] An unfavourable cervix is identifi ed in a substantial proportion of women in whom labour is induced (eg, cervical dilation 0 cm, cervical eff acement ≤25%, or posterior position of cervix) at the start of induction. In these women, the risk of caesarean section is increased. 4 A range of methods, including mechanical and pharmacological methods, are available for cervical ripening. Mechanical methods, such as transcervical Foley catheters, are among the oldest approaches used for cervical ripening. 5 Although mechanical methods are still used, pharmacological methods, including prostaglandin E1 (misoprostol) and prostaglandin E2 preparations (dinoprostone), have become treatment of choice in many countries. [6] [7] [8] [9] [10] However, cervical ripening with a Foley catheter has several advantages over pharmacological methods. 11, 12 This inexpensive method is reported to give a similar caesarean section rate to induction of labour with prostaglandins, but is associated with less hyperstimulation. [11] [12] [13] [14] [15] [16] However, diff erences in rates of fetal distress and post-partum haemorrhage between the two methods are unclear. 13 Although concerns have been raised that the use of a Foley catheter for induction of labour can increase the risk of maternal and neonatal infection, 17 such increases were not recorded in randomised controlled trials. 11, 12, 17 In view of the frequency at which the intervention is done, the variation in clinical practice, and the varying prevalence of adverse outcomes in mostly underpowered trials, 11, 12 we did this trial to compare the eff ectiveness and safety of induction of labour with a Foley catheter with induction with vaginal prostaglandin E2 gel in women with a term pregnancy and an unfavourable cervix.
Methods

Trial design
We did a prospective, open-label, multicentre randomised clinical trial, in 12 hospitals in the Netherlands. The protocol was approved by the Ethics committee of the Academic Medical Centre in Amsterdam (MEC 08/310), and the boards of all participating hospitals. The trial was registered with the Dutch trial registry, number NTR 1646.
Participants
Pregnant women scheduled for induction of labour beyond 37 weeks of gestation with a vital singleton pregnancy in cephalic presentation, intact membranes, and an unfavourable cervix (Bishop score 18 <6) were eligible for inclusion. Women younger than 18 years, with a previous caesarean section, placenta praevia, lethal fetal congenital anomaly, or known hypersensitivity for one of the products used for induction were ineligible.
Randomisation and masking
Women were informed about the study by their obstetrician when planned for labour induction and were enrolled by the attending physician, midwife, or research nurse at the delivery ward. After written informed consent was obtained, assessment of fetal condition by cardiotocography, and assessment of Bishop score, women were randomly allocated to induction with either a Foley catheter or prostaglandin E2 gel by their attending physician, in a 1:1 ratio. The randomisation sequence was computer-generated with an online randomisation programme, with variable blocks of two and four, stratifi ed for centre and parity. The randomisation sequence was not accessible by the recruiters nor the trial coordinator. The allocation code was disclosed after the a patient's initials were entered and inclusion criteria were confi rmed on the website; the unique number generated could not be deleted after wards. This study was openlabel because the nature of the intervention meant that masking to intervention was not possible.
Interventions
In the Foley catheter group a ¹⁶F or ¹⁸F Foley catheter was introduced transcervically with direct visualisation by use of a vaginal speculum. Cleaning of the cervix with an aseptic solution such as iodine or chlorhexidine was advised. After insertion past the internal os, the balloon was infl ated with 30 mL of sterile 0·9% NaCl or water, and the external end of the catheter was taped to the thigh, without traction. Women were assigned 1 h of bed rest, while fetal condition and uterine activity were monitored by cardiotocography. When the catheter was expelled from the vagina spontaneously or when a woman's Bishop score was 6 or more, the catheter was removed, amniotomy done, and continuous fetal monitoring started. If uterine activity was insuffi cient (<3 contractions per 10 min or <200 Montevideo units in case of intrauterine pressure catheter use) oxytocin was continuously infused through a syringe pump ( If the Foley catheter was not expelled spontaneously, the protocol advised to examine women at 6 h intervals, as in the prostaglandin group. Amniotomy and oxytocin infusion, as established by the attending obstetrician, were started when a woman's Bishop score was 6 or more. If the catheter was expelled but the Bishop score was less than 6, a new catheter was placed.
Women in the prostaglandin E2 group were treated mostly with a starting dose of 1 mg prostaglandin E2 gel, followed by 1 mg after 6 h, with a maximum of two doses per 24 h inserted into the posterior vaginal fornix. An initial dose of 2 mg was allowed in nulliparous women, as prescribed by the manufacturer (Pfi zer, New York, NY, USA). Amniotomy and oxytocin infusion were started when a woman's Bishop score was 6 or more, and at least 6 h after their last dose of prostaglandins. After amniotomy, continuous fetal monitoring was started.
In both groups, if the cervix was still unfavourable for amniotomy after 48 h of treatment, women were generally assigned a day of rest followed by another 48 h of induction. If after these 5 days the cervix was still unfavourable, induction was defi ned as failed and further management was decided by the treating obstetrician.
Outcomes
The primary outcome was caesarean section rate. Secondary outcomes were instrumental vaginal delivery, reasons for operative delivery, time from induction to delivery, uterine hyperstimulation (>6 contractions per 10 min more than a minimum of two 10 min periods, or a contraction lasting more than 3 min with fetal heart rate changes), uterine rupture (separation of the uterine wall), use of analgesics, use of antibiotics, maternal suspected intrapartum infection (fever ≥38°C during labour or fetal tachycardia [a sustained fetal heart rate of more than 160 beats per min] and start of broad spectrum intravenous antibiotics during labour), maternal post-partum infection (fever ≥38°C and start of antibiotics, urinary tract infection, or endometritis or myometritis proven by positive culture within 1 week post partum), post-partum haemorrhage (estimated blood loss >1000 cc in the 24 h after delivery), and postpartum blood transfusion. Secondary neonatal outcomes were Apgar scores 19 of less than 7 at 1 min and 5 min, an arterial cord blood pH of less than 7·10, neonatal admissions due to suspected infection, or infection proven by positive culture, other admissions to neonatal medium and intensive care. Baseline charac teristics, including Bishop score at the start of induction and reason for induction of labour were noted before randomisation. Trained research staff collected data using an online case report form. Serious adverse events were reported to the ethics committee of the Academic Medical Centre with specially designed forms. A data safety monitoring board was established at the start of the trial, an interim analysis was planned at 300 inclusions.
Statistical analysis
We needed a sample size of 406 patients per treatment group to show a reduction in caesarean section rate from 25% to 17% with use of the Foley catheter, with a two sided test (α error=5%; power=80%). This decrease was based on the hypothesis that less uterine hyperstimulation and, as a consequence, less caesarean sections due to fetal distress would be needed. Data were analysed on an intention-to-treat basis. Normally distributed data are presented as means with SDs, skewed distributions are presented as medians with IQRs. For categorical data,
Foley catheter (N=411)
Prostaglandin E2 gel (N=408) Data are n (%) unless otherwise indicated. *10% missing values (52 of 411 participants). †8% missing values (34 of 408 participants). ‡More than one indication possible. §Defi ned according to local hospital protocol for induction of labour, which in most cases was a gestational age ≥41 weeks. ¶Defi ned as estimated fetal weight <10th percentile. ||In this group, decreased fetal movement, maternal disease, and obstetric cholestasis were seen most often. Calculation of the percentages was based on the number of valid observations. We included footnotes in the tables and fi gures if 1% or more of information was missing. Because the data were stratifi ed for centre and parity, we also calculated RRs, CIs, and p values, which were adjusted for stratifi cation. We took parity into account as a fi xed eff ect and centre as a random eff ect in a generalised linear mixed eff ects model, created with lme4 package (version 0.999375-39).
We did an exploratory subgroup analysis to assess the consistence of the overall treatment eff ect in nulliparous and multiparous women. We used an interaction term to test the eff ect of the induction method on caesarean section rate in nullipara and multipara. We also did a post-hoc per-protocol analysis. We calculated RRs adjusted for stratifi cation in R (version 2.12.1), all other statistical analyses were done with SPSS (version 18.0). We considered p values of less than 0·05 to indicate statistical signifi cance.
Role of the funding source
There was no funding source for this study. MJ and KOR had full access to all the data in the study. MJ, KOR, BWM, and KWMB had fi nal responsibility for the decision to submit for publication
Results
Between Feb 10, 2009, and May 17, 2010, 1111 women were assessed for eligibility and 824 women were included in the trial (fi gure 1). There were no missing values for the primary outcome. All secondary outcomes had less than 1% of participants missing, except umbilical cord pH, which was missing in 23% of cases (192 of 819), evenly distributed between both groups.
Baseline characteristics were much the same between the two groups (table 1) and representative of the population of Dutch women with induced labour. 20 Postterm pregnancy and hypertensive disorders were the most frequently noted indications for induction of labour (table 1) .
None of the participants met the criteria for failed induction. We recorded no diff erence between the groups in caesarean section rate in unadjusted analysis (table 2) or after adjustment for stratifi ed randomisation (RR 1·14, 95% CI 0·88-1·46). We recorded no statistical diff erence in the frequency of vaginal instrumental deliveries between the two groups (table 2). Most caesarean sections were done for failure to progress during the fi rst stage of labour, which occurred more often in the Foley catheter group than it did in the prostaglandin group (table 2) . When combined, we recorded fewer operative deliveries for fetal distress in the Foley catheter group than in the prostaglandin gel group (table 2) .
The median time from start of induction of labour to birth was longer when a Foley catheter was used for labour induction than it was when prostaglandin gel was used (table 2) . This diff erence was only seen in the fi rst 36 h (fi gure 2), and seems to be caused by the longer interval to active labour in the Foley catheter group (fi gure 3). Labour was augmented with oxytocin more often when a Foley catheter was used than when prostaglandin gel was used (table 2) . We recorded two serious maternal adverse events, both in the prostaglandin group-one uterine perforation after insertion of an intrauterine pressure catheter and one uterine rupture during oxytocin augmentation (table 3) . Both neonates were born in good clinical condition but were admitted to the neonatal ward for 6 days because of suspected infection. We recorded four minor adverse events-three women had allergic reactions (one in the Foley catheter group and two in the prostaglandin group) and one had blood loss on insertion of the second catheter (Foley catheter group).
Hyperstimulation was not statistically diff erent between the two groups (table 3). All cases of hyper stimulation in the Foley catheter group occurred during oxytocin augmentation. Six of 12 cases of hyperstimulation in the prostaglandin group occurred after prostaglandin use only (ie, without oxytocin stimulation). We recorded no statistical diff erence in the occurrence of post-partum haemorrhage between the two groups (table 3) . We recorded fewer cases of suspected maternal infection during labour in the Foley catheter group than in the prostaglandin group (table 3) . We recorded no statistical diff erence between the two groups in number of maternal admissions post partum (219 in 411 women in the Foley catheter group vs 225 in 408 women in the prostaglandin group; RR 0·97, 95% CI 0·85-1·10) or in the median length of admission (table 3) .
Fewer neonates were admitted to the neonatal ward after induction with a Foley catheter than they were after induction with prostaglandin, but the number of admissions to a neonatal intensive-care unit was much the [10 of 144] in the prostaglandin E2 group; RR 1·21, 0·54-2·71; p interaction =0·90). However, in exploratory subgroup analysis the advantages of the Foley catheter seemed most evident for nulliparous women (webappendix p 1). At pre-planned interim analysis, done after 300 participants were enrolled, the data safety monitoring board advised to continue the trial.
Caesarean section rates were much the same between induction of labour with a Foley catheter and induction with prostaglandin in a meta-analysis that included our own data (fi gure 4). However, the reasons for caesarean section diff ered between the two groups-compared with induction of labour with prostaglandin, suspected fetal distress was recorded less often (odds ratio [OR] 0·63, 95% CI 0·45-0·90) and labour arrest was recorded more often (OR 1·52, 1·12-2·07) after induction with a Foley catheter. Compared with induction of labour with 
Discussion
Use of a Foley catheter did not reduce caesarean section rates when compared with use of prostaglandin E2 gel. After induction with a Foley catheter, the overall number of operative deliveries for suspected fetal distress was lower, fewer mothers were treated with intrapartum antibiotics, and signifi cantly fewer neonates were admitted to the neonatal ward. Induction with a Foley catheter seemed to cause less uterine hyperstimulation and post-partum haemorrhage, but this association was not statistically signifi cant. The time from the start of the intervention to birth was longer when a Foley catheter was used than when prostaglandin E2 gel was used. A meta-analysis (fi gure 4) including this trial showed no diff erence in caesarean section rates, and less hyperstimulation and post-partum haemorrhage in the Foley catheter group (panel). We recorded no statistical diff erence in the umbilical-cord pH between the two groups when our results were pooled with earlier studies. Although this is the largest study to date to compare Foley catheter induction to prostaglandin E2 gel, we recorded no statistical signifi cance in the number of adverse events in each group, probably because the number of adverse events was low. However, point estimates for all side-eff ects favour the use of the Foley catheter. We postulate that both haemorrhage and fetal distress are related to uterine hyperstimulation, which occurred more frequently after prostaglandin E2 use. Moreover the meta-analysis lent support to our fi ndings. We acknowledge that the assumed reduction of 8% in the caesarean delivery rate made in the power calculation was optimistic. Before starting the trial, information on the direct comparison between transcervical Foley catheters and vaginal prostaglandin E2 gel was scarce. Only one trial, by Prager and colleagues, 12 studied this comparison. They included 198 women in the Foley group and 191 women in the prostaglandin group. Their total caesarean section rate was, albeit non-signifi cantly, reduced in the Foley catheter group (OR 0·83, 95% CI 0·52-1·32). Prager and colleagues also noted a decrease in caesarean sections done because of fetal distress (OR 0·50, 95% CI 0·27-0·95). 12 We expected the caesarean section rate to be 25%, with 15% of these done because of fetal distress. A reduction of the caesarean section rate due to fetal distress of 50% would then result in a reduction of the overall caesarean section rate from 25% to 17%. We did not, however, anticipate such a high increase in caesarean deliveries done because of labour arrest. In view of our results, a non-inferiority design would have been more appropriate for this trial.
We did not assess the satisfaction of patients. One study 11 assessed satisfaction between women induced with a Foley catheter and prostaglandin E2 gel, and recorded no diff erence in overall satisfaction but lower pain scores in women induced with a Foley catheter (p<0·001), suggesting that Foley catheters would be a woman's preferential choice of labour induction. Although masking was impossible because of the nature of the intervention, the method of cervical ripening might have aff ected the caregivers' decision making. We believe that the non-masked nature of the trial did not cause substantial bias, because the clinical decision of doing a caesarean section is a complex one, with many factors involved.
Our fi ndings, along with the results of other randomised controlled trials, 11, 12 show that the Foley catheter and Co-ordinator searched the register with the topic list rather than with keywords. The reference lists of trial reports and reviews were manually searched by hand. We did not apply any language or date restrictions. Two reviewers (MJ and MB) identifi ed papers for relevance and quality, and extracted data. We assessed studies for quality with the Cochrane Collaboration's tool for assessing risk of bias. 21 Searching of published work yielded 122 results relevant for meta-analysis. Review of the papers indicated that two good quality studies fulfi lled the inclusion criteria. 11, 12 Both studies showed that induction with a Foley catheter is safe and eff ective. Furthermore, the study by Pennell and colleagues 11 states that it is the most acceptable method for cervical ripening in nulliparous women with unfavourable cervixes.
Interpretation
Findings from our meta-analysis, which included the results of this trial, showed that use of a Foley catheter for induction of labour does not reduce caesarean section rate when compared with use of prostaglandin E2 gel. Because our trial included many patients, we were able to investigate secondary outcomes (ie, hyperstimulation, post-partum haemorrhage, and umbilical cord pH) in the meta-analysisall such outcomes were in favour of use of a Foley catheter. Clinicians should consider a Foley catheter for induction of labour in women with an unfavourable cervix at term.
prostaglandin E2 gel give similar vaginal delivery rates, although we hypothesised that the Foley catheter would reduce caesarean deliveries. Caesarean deliveries done because of labour arrest were seen more often, whereas caesarean deliveries for fetal distress were seen less often with the use of a Foley catheter compared with use of prostaglandin gel. We think that some caesarean sections done for labour arrest in the Foley catheter group might have been done because of impatience of the attending obstetrician. This could especially be the case with obstetricians to whom Foley catheter use was new and who might have believed that use of prostaglandins was preferential. Time from start of induction to birth was substantially longer in the Foley catheter group. In the Foley catheter group, few women entered the active phase of labour during night time (induction was mostly started in the morning), whereas women in the prostaglandin group continued to start active labour at night (fi gure 3). First, we believe that induction of labour with a Foley catheter enables separation of the process of ripening of the cervix and start of labour, whereas after the use of prostaglandins these phases occur simultaneously. This occurrence is shown by the more frequent oxytocin use in the Foley catheter group and absence of hyper stimulation when only a Foley catheter was used in this trial. Second, because few women in the Foley catheter had contractions, artifi cial rupture of the membranes and start of oxytocin augmentation was possibly postponed to the next morning when the cervix was deemed favourable in the late afternoon or evening, because night-time hospital delivery increases perinatal morbidity. 22 A trial investigating the effi cacy of 12 h of ripening with a Foley catheter compared with 24 h of ripening with a Foley catheter, and ripening with vaginal prostaglandin E2 inserts, showed that shortening ripening time does not substantially aff ect the caesarean section rate, but shortens the induction-to-delivery interval to an interval similar to that with use of vaginal PGE 2 inserts. 23 We therefore postulate that earlier amniotomy in the Foley catheter group could have shortened the induction-todelivery interval.
Our unexpected fi nding of fewer cases of suspected maternal infection in the Foley catheter group could be a consequence of the greater number of vaginal examinations in the prostaglandin group. The recorded decrease in suspected maternal infections could also be a consequence of our defi nition of suspected maternal infection, in which body temperature plays a part. Because prostaglandin E2 is a mediator of the febrile response, 24 the presence of more suspected infection in the prostaglandin group could partly be explained by this fever-inducing eff ect. Nevertheless, because we cannot diff erentiate between pathogen-induced and prostaglandin E2 gel-induced fever, the fi nal result of both scenarios will be the admission of mother and child for treatment with antibiotics.
The dosing regimens used were as recommended by the manufacturer. Dosing was diff ered between centre and women's parity status. The stratifi ed analysis did not show any change in the estimator of interest (caesarean section rate). Therefore we feel that the presented data will be useful for other countries where the regimens used are the same as those used in this trial. Because of the low cost and easy storage of the Foley catheter, its use could be suitable for developing countries and low-resource settings. Another advantage of Foley catheters compared with prostaglandin E2 gel is a less stringent need for registration of contractions during cervical ripening because of the absence of hyperstimulation during ripening, which is convenient. Although the use of Foley catheters and prostaglandin E2 has been compared in low-resource settings, 14,15,25 these studies were all too small to address safety issues, and further research is needed.
Prostaglandin E2 analogues were introduced in the 1980s, without appropriately powered RCTs to prove effi cacy and safety. Our trial and meta-analysis show that induction of labour with a Foley catheter does not reduce caesarean section rates compared with vaginal prostaglandin E2 gel, however fewer side-eff ects are reported in the Foley catheter group. We therefore think that a Foley catheter should be considered for induction of labour in women with an unfavourable cervix at term. Prostaglandin E1 is becoming increasingly popular for cervical ripening worldwide. Therefore, future research should focus on the comparison of Foley catheters with other prostaglandin preparations, such as Misoprostol, and with use of Foley catheters in women with a previous caesarean birth.
